Department of General &Vascular Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Physiology, Nanjing Medical University, Jiangning District, Nanjing, China.
Eur J Vasc Endovasc Surg. 2020 Aug;60(2):254-263. doi: 10.1016/j.ejvs.2020.03.042. Epub 2020 May 16.
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signalling pathway plays a pivotal role in abdominal aortic aneurysm (AAA). However, systemic inhibition of this pathway causes serious side effects, thus limiting the clinical use of pan-PI3K inhibitors. In this study, it was hypothesised that the γ subunit of PI3K plays an important role in the PI3K/AKT signalling pathway during AAA, and that specifically targeting PI3Kγ may prevent this process.
Aortic specimens were collected from AAA patients and organ donors. Furthermore, a classical AAA model in male C57BL/6 mice was created via an intra-aortic porcine pancreatic elastase (PPE) infusion and aortas were collected. A specific PI3Kγ inhibitor, IPI-549, was administered to mice orally. The protein expression level of PI3Kγ was examined by immunohistochemistry and western blotting. The aortic leukocytes were examined by immunohistochemistry and flow cytometry.
PI3Kγ protein levels were elevated in the aortas of AAA patients and PPE infused mice. Three color immunofluorescence staining revealed the predominant area of PI3Kγ by T cells and macrophages in aneurysmal aortas. IPI-549 treatment significantly prevented AAA formation in mice. Aortic macrophages, T cells and neo-angiogenesis were significantly reduced in mice treated with IPI-549 compared with vehicle treated PPE infused mice. Flow cytometry analysis also revealed that CD45 leukocytes and CD45 F4/80 macrophages in IPI-549 treated mouse aortas decreased dramatically. Additionally, IPI-549 treatment inhibited the phosphorylation of AKT in experimental aneurysmal lesions.
Specific inhibition of PI3Kγ limits AAA formation. Targeting PI3Kγ prevents inflammatory cell infiltration through inhibition of AKT phosphorylation in AAA.
磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)信号通路在腹主动脉瘤(AAA)中发挥关键作用。然而,该通路的系统抑制会导致严重的副作用,从而限制了泛 PI3K 抑制剂的临床应用。在本研究中,假设 PI3K 的γ亚基在 AAA 中 PI3K/AKT 信号通路中发挥重要作用,并且特异性靶向 PI3Kγ 可能阻止该过程。
收集 AAA 患者和器官供体的主动脉标本。此外,通过腔内猪胰弹性蛋白酶(PPE)输注在雄性 C57BL/6 小鼠中创建经典的 AAA 模型,并收集主动脉。通过口服给予小鼠特异性 PI3Kγ 抑制剂 IPI-549。通过免疫组织化学和 Western blot 检测 PI3Kγ 的蛋白表达水平。通过免疫组织化学和流式细胞术检测主动脉白细胞。
AAA 患者和 PPE 输注小鼠的主动脉中 PI3Kγ 蛋白水平升高。三色免疫荧光染色显示,PI3Kγ 在动脉瘤主动脉中主要由 T 细胞和巨噬细胞表达。IPI-549 治疗显著预防了小鼠的 AAA 形成。与 vehicle 处理的 PPE 输注小鼠相比,IPI-549 治疗的小鼠的主动脉巨噬细胞、T 细胞和新生血管形成显著减少。流式细胞术分析还显示,IPI-549 处理的小鼠主动脉中 CD45 白细胞和 CD45 F4/80 巨噬细胞显著减少。此外,IPI-549 治疗抑制了实验性动脉瘤病变中 AKT 的磷酸化。
特异性抑制 PI3Kγ 可限制 AAA 的形成。靶向 PI3Kγ 通过抑制 AKT 磷酸化来防止 AAA 中的炎症细胞浸润。